ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Tampa, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Tampa, FL, USA:

A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

fulvestrant in patients with PIK3CA-mutated ER-positive endometrioid endometrial cancers by estimating the objective response rate ...

Enrolling
Endometroid Endometrial Cancer
Drug: Fulvestrant injection
Drug: Alpelisib Pill

Phase 2

GOG Foundation

Tampa, Florida, United States and 10 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Tampa, Florida, United States and 65 other locations

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Active, not recruiting
Endometrial Cancer
Lung Cancer
Drug: Pembrolizumab
Drug: RGX-104

Phase 1

Inspirna

Saint Petersburg, Florida, United States and 20 other locations

IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

ImmunoGen
ImmunoGen

Sarasota, Florida, United States and 8 other locations

for maintenance selinexor in participants with advanced or recurrent endometrial cancer. Participants with primary stage IV or recu...

Active, not recruiting
Endometrial Cancer
Drug: Matching placebo for selinexor
Drug: Selinexor

Phase 3

Karyopharm Therapeutics
Karyopharm Therapeutics

Tampa, Florida, United States and 77 other locations

Locations recently updated

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Tampa, Florida, United States and 202 other locations

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...

Enrolling
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endometrial Cancer
Biological: vudalimab

Phase 2

Xencor
Xencor

Tampa, Florida, United States and 16 other locations

The purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors....

Enrolling
Metastatic Cancer
Endometrial Cancer
Drug: ALTA2618

Phase 1

Alterome Therapeutics, Inc.

Sarasota, Florida, United States and 7 other locations

Phase.* Cohort A: Advanced or Metastatic Triple Negative Breast Cancer (TNBC) (IO-treated)* Cohort B: Advanced or Metastatic Triple Negative ...

Active, not recruiting
Endometrial Cancer
Solid Tumor, Unspecified, Adult
Drug: Fruquintinib
Drug: Tislelizumab

Phase 1, Phase 2

HUTCHMED
HUTCHMED

Saint Petersburg, Florida, United States and 15 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...

Enrolling
Hormone Receptor-positive/Her2 Negative Breast Cancer
High Grade Serous Ovarian Cancer
Drug: PRO1184 intravenous infusion of PRO1184
Drug: PRO1184

Phase 1, Phase 2

Genmab
Genmab

Saint Petersburg, Florida, United States and 31 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems